Company Coverage
Lens Technology (6613 HK): 2Q26: Margin Expansion Drives Earnings Beat Despite Smartphone Revenue Drag
BUY (Maintained)
Current price:
Target price:
Upside:
Previous TP :
HK$22.96
HK$43.10
+87.7%
HK$43.70
Analyst
Analyst
Highlights
Net profit beat consensus by 48.7% to Rmb726m amid low expectations, driven by strong margin improvements across key segments through yield gains and higher-value product mix.
Smartphone headwinds are bottoming out, while auto segment margin expansion and new emerging tech initiatives will support long-term growth.
Maintain BUY. Target price trimmed to HK$43.10.

Analysis
Margin expansion drove a solid 2Q26 profit beat. Revenue fell 7.4% yoy but grew 4.2% qoq to Rmb14.7b, marginally below consensus estimates of Rmb14.9b, largely due to shipment volume weakness in consumer devices. Gross margin expanded 2.5ppt yoy and 3.7ppt qoq to 18.2%, 2.5ppt above consensus, due to cuts in the low-margin assembly business and improvements in yields. This supported a net profit growth of 1.8% yoy to Rmb726m, swinging from 1Q26’s Rmb150m net loss, which is a 48.7% beat compared with consensus.

Highlights
Net profit beat consensus by 48.7% to Rmb726m amid low expectations, driven by strong margin improvements across key segments through yield gains and higher-value product mix.
Smartphone headwinds are bottoming out, while auto segment margin expansion and new emerging tech initiatives will support long-term growth.
Maintain BUY. Target price trimmed to HK$43.10.

Analysis
Margin expansion drove a solid 2Q26 profit beat. Revenue fell 7.4% yoy but grew 4.2% qoq to Rmb14.7b, marginally below consensus estimates of Rmb14.9b, largely due to shipment volume weakness in consumer devices. Gross margin expanded 2.5ppt yoy and 3.7ppt qoq to 18.2%, 2.5ppt above consensus, due to cuts in the low-margin assembly business and improvements in yields. This supported a net profit growth of 1.8% yoy to Rmb726m, swinging from 1Q26’s Rmb150m net loss, which is a 48.7% beat compared with consensus.

BUY (Maintained)
Current price:
Target price:
Upside:
Previous TP :
HK$22.96
HK$43.10
+87.7%
HK$43.70
Analyst
Analyst
IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at this link, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.
Related articles

21 Aug 2026
Alibaba Group (9988 HK): 1QFY27: In-line Results; Cloud Revenue And EBITA Margin Beat; High Capex/FCF Outflow

21 Aug 2026
Han’s Laser (002008 CH): 2Q26: Robust Growth With Beats Across The Board

20 Aug 2026
Ping An Healthcare and Technology Company (1833 HK): 1H26: Bottom Line Beat On Margin Expansion; Non-core Business Run-off Weighs On 2026 Revenue
Our latest research

26 Aug 2026
WuXi Biologics (Cayman) (2269 HK): 1H26: Exceeds Expectations; Robust Demand Fuels Accelerated Growth

26 Aug 2026
Xtep International Holdings (1368 HK): 1H26: Revenue Misses But Gross Margin Expansion Drives Better-Than-Expected Net Profit; Lowers Full-Year Revenue Target

26 Aug 2026
